Diagnosis of hyperlipidemia and treatment with a statin in the outpatient stroke clinic

Journal of Stroke and Cerebrovascular Diseases

Volumn 10, Issue 3, 2001, Pages 132-134

  Gomes, Joao ^a,b,c   Wu, Chuang Kuo ^a,b,c   Schauble, Barbara ^a,b,c   Winter, Michael R ^a,b,c   Chamlian, Vana ^a,b,c   Allen, Nancy C ^a,b,c   Babikian, Viken L ^a,b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cerebrovascular disorders; Cholesterol; Hyperlipidemia

Indexed keywords

FLUINDOSTATIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; STATIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; HEALTH CARE DELIVERY; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STROKE;

EID: 0034926878     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1053/jscd.2001.25465     Document Type: Article

References (8)

1. Summary of the NCEP adult treatment panel II report
2. Reduction of stroke incidence after myocardial infarction with pravastatin
3. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLACII)
4. Pravastatin therapy and the risk of stroke
5. Cholesterol reduction and stroke occurrence: An overview of randomized clinical trials
6. Effect of lovastatin on early carotid atherosclerosisand cardiovascular events
7. Cholesterol-lowering therapy in diabetic and elderly coronary artery disease patients
8. The imperative to develop dedicated stroke centers